Mr Lister will serve on the board’s compensation committee and will focus on guiding the company in the commercialization of new molecular assays.
Most recently, Mr Lister was the senior vice president and general manager of patient care at Roche Diagnostics. Mr Lister has received a bachelor of science degree in management and a master of science degree in marketing from Indiana State University.
John Climaco, president and CEO of Axial Biotech, said: “Bill has a very impressive record in the diagnostics industry of creating and executing major strategies as well as helping companies build the foundation for meaningful and sustained growth. His skills will be instrumental in helping the company achieve its new expansion imperatives.”